- Home
- RGR vs STOK Comparison
RGR vs STOK Comparison
Compare RGR & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGR
- STOK
- Stock Information
- Founded
- RGR 1949
- STOK 2014
- Country
- RGR United States
- STOK United States
- Employees
- RGR N/A
- STOK N/A
- Industry
- RGR Ordnance And Accessories
- STOK Biotechnology: Pharmaceutical Preparations
- Sector
- RGR Industrials
- STOK Health Care
- Exchange
- RGR Nasdaq
- STOK Nasdaq
- Market Cap
- RGR 610.8M
- STOK 721.4M
- IPO Year
- RGR N/A
- STOK 2019
- Fundamental
- Price
- RGR $35.70
- STOK $9.36
- Analyst Decision
- RGR
- STOK Strong Buy
- Analyst Count
- RGR 0
- STOK 8
- Target Price
- RGR N/A
- STOK $21.83
- AVG Volume (30 Days)
- RGR 177.2K
- STOK 933.4K
- Earning Date
- RGR 02-19-2025
- STOK 11-05-2024
- Dividend Yield
- RGR 1.93%
- STOK N/A
- EPS Growth
- RGR N/A
- STOK N/A
- EPS
- RGR 1.73
- STOK N/A
- Revenue
- RGR $520,485,000.00
- STOK $16,742,999.00
- Revenue This Year
- RGR N/A
- STOK $105.42
- Revenue Next Year
- RGR $4.81
- STOK N/A
- P/E Ratio
- RGR $20.59
- STOK N/A
- Revenue Growth
- RGR N/A
- STOK 81.08
- 52 Week Low
- RGR $34.11
- STOK $4.09
- 52 Week High
- RGR $48.20
- STOK $17.58
- Technical
- Relative Strength Index (RSI)
- RGR 48.45
- STOK 36.22
- Support Level
- RGR $35.24
- STOK $8.42
- Resistance Level
- RGR $36.18
- STOK $9.77
- Average True Range (ATR)
- RGR 0.77
- STOK 0.66
- MACD
- RGR 0.25
- STOK -0.09
- Stochastic Oscillator
- RGR 70.04
- STOK 28.40
About RGR Sturm Ruger & Company Inc.
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The Company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.
About STOK Stoke Therapeutics Inc.
Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S.